Valuation: DocMorris AG

Market Cap 425M 526M 460M 392M 745M 50.2B 758M 5.09B 1.99B 24.71B 1.98B 1.93B 85.45B P/E 2026 *
-5.47x
P/E 2027 * -10.4x
Enterprise Value 626M 775M 678M 578M 1.1B 74B 1.12B 7.5B 2.93B 36.41B 2.91B 2.85B 126B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.48x
Free-Float
66.58%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 546M
-1.42%+7.44%-18.69%-5.53% 6.11B
-0.49%+5.83%-18.46%-34.22% 3.61B
-4.34%-2.83%-38.74%-11.08% 3.2B
-1.02%-1.92%-29.42%-46.88% 3.21B
-0.90%+9.29%+3.34%-35.18% 2.98B
-3.79%+0.28%-21.01%-4.41% 2.54B
+1.66%-2.54%+95.99% - 2.56B
-0.86%-2.45%-1.41%+39.42% 1.67B
-8.05%-10.62%-32.30%-43.12% 1.55B
Average -1.92%+0.23%-6.74%-17.63% 3.05B
Weighted average by Cap. -1.77%+1.53%-9.10%-18.50%

Financials

2026 *2027 *
Net sales 1.22B 1.51B 1.32B 1.13B 2.14B 144B 2.18B 14.61B 5.72B 70.96B 5.68B 5.55B 245B 1.37B 1.7B 1.49B 1.27B 2.41B 162B 2.45B 16.43B 6.43B 79.78B 6.38B 6.24B 276B
Net income -83.51M -103M -90.5M -77.14M -147M -9.87B -149M -1B -392M -4.86B -389M -380M -16.81B -46.79M -57.97M -50.7M -43.22M -82.13M -5.53B -83.53M -561M -219M -2.72B -218M -213M -9.42B
Net Debt 201M 249M 218M 186M 353M 23.79B 359M 2.41B 944M 11.71B 937M 916M 40.5B 238M 295M 258M 220M 419M 28.19B 426M 2.86B 1.12B 13.87B 1.11B 1.09B 47.98B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
8.685CHF
Average target price
7.756CHF
Spread / Average Target
-10.69%

Quarterly revenue - Rate of surprise